10-Q will be filed later this week .
As expected, for the third quarter ending September 30, 2015, the Company again registered a large loss from operation. The vast majority of which consisted of non-cash stock-based compensation expense, along with legal and professional costs primarily associated with our second Form S-1 filing to raise additional capital and our 14-C filing to increase the number of authorized shares of common stock. We also posted $289,000 in revenues for the quarter, significantly up from $84,000 in the preceding second quarter and $148,000 last year. About half the revenues came from consulting fees and contributions from our Vaporfection subsidiary, along with some one-time non-recurring amounts.
